Failure to respond at 1‐4 weeks · patients with depression
1 finding from 1 review
Failure to respond at 16‐24 weeks · patients with depression
Paroxetine showed no clear difference in failure to respond at 16‐24 weeks compared with nefazodone (moderate certainty).
1 finding from 1 review
Failure to remit at endpoint · patients with depression
1 finding from 1 review
SMD at endpoint · patients with depression
1 finding from 1 review
Failure to complete ‐ any cause ‐ · patients with depression
Paroxetine showed no clear difference in failure to complete ‐ any cause ‐ compared with nefazodone (moderate certainty).
1 finding from 1 review
Participants with at least some Side Effects · patients with depression
Paroxetine showed no clear difference in participants with at least some Side Effects compared with nefazodone (moderate certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · patients with depression
Paroxetine showed no clear difference in failure to respond at endpoint (6‐12 weeks) compared with reboxetine (moderate certainty).
1 finding from 1 review
panic symptoms · participants with panic disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability ‐ total dropouts · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for any reason number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Acceptability ‐ dropouts due to adverse effects · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for adverse effects number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Improvment of social function: Self‐reported social adaptation scale (SASS) (low=poor), acute effect SASS. Scale from: 0 to 60. · participants with panic disorder
1 finding from 1 review
Quality of life Short‐Form 36 health survey (SF‐36) · participants with panic disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Safety of rTMS: Frequency of rTMS side effects (values are percentages) self‐reported questionnaire · participants with panic disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction on a scale of psychological distress— · people of any age who have survived any type of torture
1 finding from 1 review
Adverse events · people of any age who have survived any type of torture
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction in post‐traumatic stress symptoms— · people of any age who have survived any type of torture
1 finding from 1 review
Improvement in quality of life— · people of any age who have survived any type of torture
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in participation · people of any age who have survived any type of torture
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in family or social relationships · people of any age who have survived any type of torture
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with treatment · people of any age who have survived any type of torture
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found